BioWorld MedTech

Dec. 31, 2014

CytoSorbents seeks IDE for intra-operative use of CytoSorb treatment

A device designed to be installed into a heart-lung machine and used intra-operatively during complex cardiac surgery in an effort to reduce post-operative complications may soon be making its way through the U.S. regulatory process. Read More

Six leading research centers launch Cancer Core Europe

Alpinion Medical Systems rolls out South Korea's first HIFU

Kalorama identifies top trends that impacted med-tech in 2014

Abbott sheds light on early results for tender offer

Heart Sync electrode latest in slew of recalls related to Philips AEDs

Briefly Noted

Modernizing Medicine completes acquisition of Aesyntix Health

Keeping you up to date on recent events with Oncology

Today's news in brief

BioWorld

BioWorld briefs for Jan 23, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...